252 related articles for article (PubMed ID: 26778103)
1. Development of daptomycin resistance during therapy in a patient with methicillin-resistant Staphylococcus aureus endocarditis: A case report.
Sotillo A; Paño-Pardo JR; López-Quintana B; Gómez-Gil R
Enferm Infecc Microbiol Clin; 2016 Oct; 34(8):534-5. PubMed ID: 26778103
[No Abstract] [Full Text] [Related]
2. In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.
Dortet L; Anguel N; Fortineau N; Richard C; Nordmann P
Int J Infect Dis; 2013 Nov; 17(11):e1076-7. PubMed ID: 23578850
[TBL] [Abstract][Full Text] [Related]
3. Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
Nigo M; Diaz L; Carvajal LP; Tran TT; Rios R; Panesso D; Garavito JD; Miller WR; Wanger A; Weinstock G; Munita JM; Arias CA; Chambers HF
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28232309
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Joson J; Grover C; Downer C; Pujar T; Heidari A
J Antimicrob Chemother; 2011 Sep; 66(9):2186-8. PubMed ID: 21653600
[No Abstract] [Full Text] [Related]
5. Successful Use of High-dose Daptomycin in a Child With Staphylococcus aureus Endocarditis.
Prabhudesai S; Kanjani A; Nambi PS; Gnanasambandam S; Ramachandran B
Pediatr Infect Dis J; 2016 May; 35(5):517-8. PubMed ID: 27074655
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial salvage therapy for native valve MRSA endocarditis.
Cortes J; Sagar AS; Lee Y; Sandhu U; Boka K
J Antimicrob Chemother; 2017 Jun; 72(6):1841-1842. PubMed ID: 28333236
[No Abstract] [Full Text] [Related]
7. Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE).
Cunha BA; Pherez FM
Eur J Clin Microbiol Infect Dis; 2009 Jul; 28(7):831-3. PubMed ID: 19184141
[TBL] [Abstract][Full Text] [Related]
8. Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
Gqada Z; Marais B; Wasserman E; Bamford C; Orth H; Sakoulas G; Rose W; Rybak MJ; Pillai S; Alder J; Moellering RC; Eliopoulos GM
J Clin Microbiol; 2008 Jul; 46(7):2471; author reply 2471-2. PubMed ID: 18614667
[No Abstract] [Full Text] [Related]
9. [The second life of daptomycin: analysis of a successful come-back].
Decousser JW; Doucet Populaire F
Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200
[No Abstract] [Full Text] [Related]
10. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.
Miró JM; Entenza JM; Del Río A; Velasco M; Castañeda X; Garcia de la Mària C; Giddey M; Armero Y; Pericàs JM; Cervera C; Mestres CA; Almela M; Falces C; Marco F; Moreillon P; Moreno A;
Antimicrob Agents Chemother; 2012 Aug; 56(8):4511-5. PubMed ID: 22644033
[TBL] [Abstract][Full Text] [Related]
11. Treatment of tricuspid valve endocarditis with daptomycin and linezolid therapy.
Galanter KM; Ho J
Am J Health Syst Pharm; 2019 Jul; 76(14):1033-1036. PubMed ID: 31201773
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin as successful treatment for a refractory case of prosthetic valve endocarditis because of methicillin-sensitive Staphylococcus aureus.
Cheung LL; Yue CS; Fung K; Chu CM; Keung Tso EY
Heart Lung; 2011; 40(2):172-6. PubMed ID: 20800283
[TBL] [Abstract][Full Text] [Related]
13. Development of multiple lung abscesses during daptomycin treatment for right-sided endocarditis caused by meticillin-resistant Staphylococcus aureus.
Liu CY; Wang JL; Huang YT; Hsueh PR
Int J Antimicrob Agents; 2008 Dec; 32(6):544-5. PubMed ID: 18789850
[No Abstract] [Full Text] [Related]
14. Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.
Jongsma K; Joson J; Heidari A
J Antimicrob Chemother; 2013 Jun; 68(6):1444-5. PubMed ID: 23341127
[No Abstract] [Full Text] [Related]
15. Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Jacqueline C; Amador G; Batard E; Le Mabecque V; Miègeville AF; Biek D; Caillon J; Potel G
J Antimicrob Chemother; 2011 Apr; 66(4):863-6. PubMed ID: 21393213
[TBL] [Abstract][Full Text] [Related]
16. In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis.
Kirby A; Mohandas K; Broughton C; Neal TJ; Smith GW; Pai P; Nistal de Paz C
J Med Microbiol; 2009 Mar; 58(Pt 3):376-380. PubMed ID: 19208891
[TBL] [Abstract][Full Text] [Related]
17. Meticillin-resistant Staphylococcus aureus endocarditis: first report of daptomycin plus ceftobiprole combination as salvage therapy.
Oltolini C; Castiglioni B; Tassan Din C; Castiglioni A; Ossi C; La Canna G; Pajoro U; Scarpellini P
Int J Antimicrob Agents; 2016 Jun; 47(6):502-4. PubMed ID: 27211210
[No Abstract] [Full Text] [Related]
18. Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
Singh KV; Arias CA; Murray BE
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122892
[TBL] [Abstract][Full Text] [Related]
19. Comment on: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Camou F
J Antimicrob Chemother; 2012 Feb; 67(2):514; author reply 515. PubMed ID: 22081266
[No Abstract] [Full Text] [Related]
20. Comment on: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Cleveland KO; Memon KA
J Antimicrob Chemother; 2011 Dec; 66(12):2891; author reply 2891-2. PubMed ID: 21903659
[No Abstract] [Full Text] [Related]
[Next] [New Search]
